Influence of host interleukin-10 polymorphisms on development of traveler's diarrhea due to heat-labile enterotoxin-producing Escherichia coli in travelers from the United States who are visiting Mexico

Clinical and Vaccine Immunology

Volumn 15, Issue 8, 2008, Pages 1194-1198

  Flores, Jose ^a   DuPont, Herbert L ^b,c,e   Lee, Stephanie A ^a   Belkind Gerson, Jaime ^d   Paredes, Mercedes ^a   Mohamed, Jamal A ^a   Armitige, Lisa Y ^a   Guo, Dong Chuan ^a   Okhuysen, Pablo C ^a,c,e  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b ST LUKE S EPISCOPAL HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

^d INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^e BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLERA TOXIN; ESCHERICHIA COLI ENTEROTOXIN; INTERLEUKIN 10;

ADULT; ARTICLE; CONTROLLED STUDY; ENTEROTOXIGENIC ESCHERICHIA COLI; FEMALE; GENETIC PREDISPOSITION; GENOTYPE; HAPLOTYPE; HUMAN; IMMUNOPATHOGENESIS; INFECTION SENSITIVITY; MAJOR CLINICAL STUDY; MALE; MEXICO; PRIORITY JOURNAL; PROMOTER REGION; PYROSEQUENCING; SEROCONVERSION; SINGLE NUCLEOTIDE POLYMORPHISM; TRAVEL; TRAVELLER DIARRHEA; UNITED STATES;

ADULT; BACTERIAL TOXINS; DIARRHEA; ENTEROTOXIGENIC ESCHERICHIA COLI; ENTEROTOXINS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; FEMALE; HUMANS; INTERLEUKIN-10; MALE; MEXICO; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; TRAVEL; UNITED STATES;

EID: 49149083332     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00070-08     Document Type: Article

References (29)

1. Adachi, J. A., C. D. Ericsson, Z. D. Jiang, M. W. DuPont, S. R. Pallegar, and H. L. DuPont. 2002. Natural history of enteroaggregative and enterotoxigenic Escherichia coli infection among US travelers to Guadalajara, Mexico. J. Infect. Dis. 185:1681-1683.
2. Berg, D. J., N. Davidson, R. Kühn, W. Müller, S. Menon, G. Holland, L. Thompson-Snipes, M. W. Leach, and D. Rennick. 1996. Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses. J. Clin. Investig. 98: 1010-1020.
3. Bouckenooghe, A. R., Z. D. Jiang, F. J. De La Cabada, C. D. Ericsson, and H. L. DuPont. 2002. Enterotoxigenic Escherichia coli as cause of diarrhea among Mexican adults and US travelers in Mexico. J. Travel Med. 9:137-140.
4. Bozzi, A., P. P. Pereira, B. S. Reis, M. I. Goulart, M. C. Pereira, E. P. Pedroso, M. F. Leite, and A. M. Goes. 2006. Interleukin-10 and tumor necrosis factor-alpha single nucleotide gene polymorphism frequency in paracoccidioidomycosis. Hum. Immunol. 67:931-939.
5. Reference deleted.
6. Cheong, J. Y., S. W. Cho, I. L. Hwang, S. K. Yoon, J. H. Lee, C. S. Park, J. E. Lee, K. B. Hahm, and J. H. Kim. 2006. Association between chronic hepatitis B virus infection and interleukin-10, tumor necrosis factor-alpha gene promoter polymorphisms. J. Gastroenterol. Hepatol. 21:1163-1169.
7. Clemens, J. D., A. M. Svennerholm, J. R. Harris, S. Huda, M. Rao, P. K. Neogy, M. R. Khan, M. Ansaruzzaman, S. Rahaman, and F. Ahmed. 1990. Seroepidemiologic evaluation of anti-toxic and anti-colonization factor immunity against infections by LT-producing Escherichia coli in rural Bangladesh. J. Infect. Dis. 162:448-453.
8. Clemens, J., S. Savarino, R. Abu-Elyazeed, M. Safwat, M. Rao, T. Wierzba, A. M. Svennerholm, J. Holmgren, R. Frenck, E. Park, and A. Naficy. 2004. Development of pathogenicity-driven definitions of outcomes for a field trial of a killed oral vaccine against enterotoxigenic Escherichia coli in Egypt: application of an evidence-based method. J. Infect. Dis. 189:2299-2307.
9. Elson, C. J., and W. Ealding. 1984. Generalised systemic and mucosal immunity in mice after mucosal stimulation with cholera toxin. J. Immunol. 132:2736-2743.
10. Jiang, Z. D., P. C. Okhuysen, D. C. Guo, R. He, T. M. King, H. L. DuPont, and D. M. Milewicz. 2003. Genetic susceptibility to enteroaggregative Escherichia coli diarrhea: polymorphism in the interleukin-8 promoter region. J. Infect. Dis. 188:506-511.
11. Jiang, Z. D., J. J. Mathewson, C. D. Ericsson, A. M. Svennerholm, C. Pulido, and H. L. DuPont. 2000. Characterization of enterotoxigenic Escherichia coli strains in patients with travelers' diarrhea acquired in Guadalajara, Mexico, 1992-1997. J. Infect. Dis. 181:779-782.
12. Kim, S. C., S. L. Tonkonogy, C. A. Albright, J. Tsang, E. J. Balish, J. Braun, M. M. Huycke, and R. B. Sartor. 2005. Variable phenotypes of enterocolitis in interleukin 10-deficient mice monoassociated with two different commensal bacteria. Gastroenterology 128:891-906.
13. Ko, G., C. Garcia, Z. D. Jiang, P. C. Okhuysen, J. Belkind-Gerson, R. I. Glass, and H. L. DuPont. 2005. Noroviruses as a cause of traveler's diarrhea among students from the United States visiting Mexico. J. Clin. Microbiol. 43:6126-6129.
14. Ko, G., Z. D. Jiang, P. C. Okhuysen, and H. L. DuPont. 2006. Fecal cytokines and markers of intestinal inflammation in international travelers with diarrhea due to noroviruses. J. Med. Virol. 78:825-828.
15. Lopez-Saucedo, C., J. F. Cerna, N. Villegas-Sepulveda, R., Thompson, F. R. Velazquez, J. Torres, P. I. Tarr, and T. Estradu-Garciu. 2003. Single multiplex polymerase chain reaction to detect diverse loci associated with diarrheagenic Escherichia coli. Emerg. Infect. Dis. 9:127-131.
16. Mattila, L., A. Siitonen, H. Kyronseppa, I. Simula, P. Oksanen, M. Stenvik, P. Salo, H. Peltola, et al. 1992. Seasonal variation in etiology of travelers' diarrhea. J. Infect. Dis. 165:385-388.
17. Mohamed, J. A., H. L. DuPont, Z. D. Jiang, J. Belkind-Gerson, J. F. Figueroa, L. Y. Armitige, A. Tsai, P. Nair, F. J. Martinez-Sandoval, D. C. Guo, P. Hayes, and P. C. Okhuysen. 2007. A novel single-nucleotide polymorphism in the lactoferrin gene is associated with susceptibility to diarrhea in North American travelers to Mexico. Clin. Infect. Dis. 44:945-952.
18. Okhuysen, P. C., Z. D. Jiang, L. Carlin, C. Forbes, and H. L. DuPont. 2004. Post-diarrhea chronic intestinal symptoms and irritable bowel syndrome in North American travelers to Mexico. Am. J. Gastroenterol. 99:1774-1778.
19. Rao, M. R., T. F. Wierzba, S. J. Savarino, R. Abu-Elyazeed, N. El-Ghoreb, E. R. Hall, A. Naficy, I. Abdel-Messih, R. W. Frenck, Jr., A. M. Svennerholm, and J. D. Clemens. 2005. Serologic correlates of protection against enterotoxigenic Escherichia coli diarrhea. J. Infect. Dis. 191:562-570.
20. Ryan, E. J., E. McNeela, M. Pizza, R. Rappuoli, L. O'Neill, and K. H. Mills. 2000. Modulation of innate and acquired immune responses by Escherichia coli heat-labile toxin: distinct pro- and anti-inflammatory effects of the nontoxic AB complex and the enzyme activity. J. Immunol. 165:5750-5759.
21. Sainz, J., L. Hassan, E. Perez, A. Romero, A. Moratalla, E. López-Fernández, S. Oyonarte, and M. Jurado. 2007. Interleukin-10 promoter polymorphism as risk factor to develop invasive pulmonary aspergillosis. Immunol. Lett. 109:76-82.
22. Schaaf, B. M., F. Boehmke, H. Esnaashari, U. Seitzer, H. Kothe, M. Maass, P. Zabel, and K. Dalhoff. 2003. Pneumococcal septic shock is associated with the interleukin-10-1082 gene promoter polymorphism. Am. J. Respir. Crit. Care Med. 168:476-480.
23. Sinha, S., K. N. Prasad, D. Jain, C. M. Pandey, S. Jha, and S. Pradhan. 2007. Preceding infections and anti-ganglioside antibodies in patients with Guillain-Barré syndrome: a single centre prospective case-control study. Clin. Microbiol. Infect. 13:334-337.
24. Steffen, R. 2005. Epidemiology of travelers' diarrhea. Clin. Infect. Dis. 41:S536-S540.
25. Turcanu, V., T. R. Hirst, and N. A. Williams. 2002. Modulation of human monocytes by Escherichia coli heat-labile enterotoxin B-subunit; altered cytokine production and its functional consequences. Immunology 106:316-325.
26. von Sonnenburg, F., N. Tornieporth, P. Waiyaki, B. Lowe, L. F. Peruski, Jr., H. L. DuPont, J. J. Mathewson, and R. Steffen. 2000. Risk and aetiology of diarrhoea at various tourist destinations. Lancet 356:133-134.
27. Wang, P., P. Wu, M. I. Siegel, R. W. Egan, and M. M. Billah. 1995. Interleukin (IL)-10 inhibits nuclear factor kappa B (NF kappa B) activation in human monocytes. IL-10 and IL-4 suppress cytokine synthesis by different mechanisms. J. Biol. Chem. 270:9558-9563.
28. Yates, J. A., and L. C. Stetz. 2006. Reiter's syndrome (reactive arthritis) and travelers' diarrhea. J. Travel Med. 13:54-56.
29. Zhang, Z., W. Liu, X. Jia, Y. Gao, K. Hemminki, and M. Linholm. 2004. Use of pyrosequencing to detect clinically relevant polymorphisms of genes in basal cell carcinoma. Clin. Chim. Acta 342:137-143.